GenFleet Therapeutics (Shanghai) Inc. (HKG:2595)

HKG:2595 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Apr 1, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Market Capitalization	13,518	8,807	-	-
Enterprise Value	11,322	8,510	-	-
Last Close Price	36.50	23.78	-	-
PS Ratio	93.25	60.76	-	-
PB Ratio	6.69	4.36	-	-
P/TBV Ratio	6.70	4.36	-	-
EV/Sales Ratio	78.10	58.71	-	-
Debt / Equity Ratio	0.06	0.06	-0.04	-0.02
Net Debt / Equity Ratio	-1.09	-1.09	0.17	0.23
Net Debt / EBITDA Ratio	7.27	7.27	1.21	1.10
Net Debt / FCF Ratio	-	-	1.58	1.48
Asset Turnover	0.09	0.09	0.18	-
Inventory Turnover	4.07	4.07	5.26	-
Quick Ratio	5.66	5.66	0.21	0.23
Current Ratio	5.85	5.85	0.23	0.25
Return on Assets (ROA)	-12.49%	-12.49%	-30.27%	-
Return on Capital Employed (ROCE)	-15.30%	-15.30%	14.70%	22.10%
Earnings Yield	-14.77%	-22.67%	-	-
Buyback Yield / Dilution	-1043.91%	-1043.91%	-17.40%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.